1. Adams, D. J., Watkins, P. J., Knick, V. C., Tuttle, R. L. & Bair, K. W. Evaluation of arylmethylaminopropanediols by a novel in vitro pharmacodynamic assay: correlation with antitumor activity in vivo. Cancer Res 50, 3663–3669 (1990).
2. Olaussen, K. A. et al. DNA repair by ERCC1 in non–small-cell lung cancer and cisplatin-based adjuvant chemotherapy. New England Journal of Medicine 355, 983–991 (2006).
3. Roos, W. P. & Kaina, B. DNA damage-induced cell death by apoptosis. Trends Mol Med 12, 440–450,
https://doi.org/10.1016/j.molmed.2006.07.007
(2006).
4. CISplatin Injection. FDA Report Reference ID: 3708516. Report No. 3708516, (
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018057s083lbl.pdf
, 2015).
5. Khan, F., Anker, C. J., Garrison, G. & Kinsey, C. M. Endobronchial Ultrasound–Guided Transbronchial Needle Injection for Local Control of Recurrent Non–Small Cell Lung Cancer. Annals of the American Thoracic. Society 12, 101–104 (2015).